Safety and efficacy of omalizumab for antihistamine-resistant chronic urticaria in children: a case series and literature review

World J Pediatr. 2023 Sep 19. doi: 10.1007/s12519-023-00760-4. Online ahead of print.NO ABSTRACTPMID:37725321 | DOI:10.1007/s12519-023-00760-4
Source: World Journal of Pediatrics : WJP - Category: Pediatrics Authors: Source Type: research
More News: Children | Hives | Pediatrics | Xolair